Atlas Capital Advisors LLC
- SEC CIK
- 0001434165
- Latest filing
- Aug 13, 2026
The latest 13F from Atlas Capital Advisors LLC covers Q2 2026 (filed Aug 13, 2026): 1,049 long positions worth $914.0M. The top 10 holdings make up 20.2% of the portfolio, and the largest is Vanguard Intl Equity Index F at 4.7%. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.
What changed in Q2 2026
Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.
- New
- 136
- Est. +$16.5M
- Added
- 349
- Est. +$79.8M
- Reduced
- 251
- Est. −$152.5M
- Sold out
- 75
- Est. −$34.9M
Top 5 holdings
Share of this quarter's portfolio value
- Vanguard Intl Equity Index F9220428744.7%$43.4M
- State Street Technology Select Sector SPDR ETF81369Y8032.5%$23.0M
- iShares Inc46434G7642.2%$20.1M
- SPDR Index Shs FDS78463X5092.1%$18.9M
- iShares Tr46434V4491.9%$17.3M
Share of portfolio
Top 5 holdings and the other 1,044 positions, by share of portfolio value
- Vanguard Intl Equity Index F4.7%
- State Street Technology Select Sector SPDR ETF2.5%
- iShares Inc2.2%
- SPDR Index Shs FDS2.1%
- iShares Tr1.9%
- Other 1,044 positions86.6%
Biggest buys
New and added positions, by estimated amount bought
- iShares Tr46434V449+$3.61MAdded
- Dimensional ETF Trust25434V807+$3.50MAdded
- State Street SPDR Bloomberg 1-3 Month T-Bill ETF78468R663+$3.00MAdded
- Vanguard Morningstar Small-Cap Value ETF922908611+$2.10MAdded
- Invesco S&P 500 Equal Weight Technology ETF46137V282+$1.72MAdded
Largest weight increases
New and added positions, by percentage points of the portfolio gained
- State Street Technology Select Sector SPDR ETF81369Y803+0.76 pp1.8% → 2.5%
- iShares Inc46434G764+0.57 pp1.6% → 2.2%
- AMATApplied Materials Inc
- iShares Tr46434V449+0.48 pp1.4% → 1.9%
- Invesco S&P 500 Equal Weight Technology ETF46137V282+0.46 pp0.7% → 1.2%
Biggest sells
Reduced and sold-out positions, by estimated amount sold
Largest weight decreases
Reduced and sold-out positions, by percentage points of the portfolio lost
Metrics
13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.
- Portfolio value
- $914.0M
- +$39.7M (+4.5%) vs. prior quarter
- Positions
- 1,049
- +61 vs. prior quarter
- Top 10 concentration
- 20.2%
- Top 10 as share of value
- Turnover
- 10.8%
- Q2 2026, one quarter
- Average holding period
- 2.9 quarters
- Weighted by value
How these are calculated
- Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
- Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
- Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
- Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.
13F filings by quarter
21 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.
Peak $914.0M (Q2 2026)
| Quarter | Filed | Positions | Value | Top 3 holdings | Changes | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 13, 2026Amended | 1,049 | $914.0M | Vanguard Intl Equity Index FState Street Technology Select Sector SPDR ETFiShares Inc | vs. Q1 2026 | SEC |
| Q1 2026 | May 11, 2026 | 988 | $874.2M | PGVanguard Intl Equity Index FPLMR | vs. Q4 2025 | SEC |
| Q4 2025 | Feb 13, 2026 | 971 | $897.6M | PGVanguard Intl Equity Index FPLMR | – | SEC |
| Q2 2025 | Aug 12, 2025 | 922 | $818.1M | PGVanguard Intl Equity Index FPLMR | vs. Q1 2025 | SEC |
| Q1 2025 | May 12, 2025 | 981 | $799.8M | PGVanguard Intl Equity Index FPLMR | vs. Q4 2024 | SEC |
| Q4 2024 | Feb 12, 2025 | 927 | $785.2M | PGState Street Technology Select Sector SPDR ETFMSFT | vs. Q3 2024 | SEC |
| Q3 2024 | Nov 5, 2024 | 902 | $653.4M | State Street Technology Select Sector SPDR ETFVanguard Intl Equity Index FSPDR Index Shs FDS | vs. Q2 2024 | SEC |
| Q2 2024 | Jul 30, 2024 | 891 | $767.8M | PGMSFTState Street Technology Select Sector SPDR ETF | vs. Q1 2024 | SEC |
| Q1 2024 | Apr 15, 2024 | 890 | $639.9M | State Street Technology Select Sector SPDR ETFiShares TriShares Tr | vs. Q4 2023 | SEC |
| Q4 2023 | Feb 15, 2024 | 898 | $690.3M | PGVanguard Total World Stock ETFMSFT | vs. Q3 2023 | SEC |
| Q3 2023 | Nov 14, 2023 | 871 | $607.4M | PGMSFTiShares Tr | vs. Q2 2023 | SEC |
| Q2 2023 | Aug 15, 2023 | 890 | $658.3M | PGMSFTiShares Tr | vs. Q1 2023 | SEC |
| Q1 2023 | May 16, 2023 | 900 | $635.5M | PGMSFTPLMR | vs. Q4 2022 | SEC |
| Q4 2022 | Feb 15, 2023 | 892 | $594.9M | PGiShares TrVanguard Health Care ETF | vs. Q3 2022 | SEC |
| Q3 2022 | Nov 8, 2022 | 915 | $548.2M | PGiShares TrVanguard Intl Equity Index F | vs. Q2 2022 | SEC |
| Q2 2022 | Aug 16, 2022 | 971 | $589.0M | PGiShares TriShares Tr | vs. Q1 2022 | SEC |
| Q1 2022 | May 11, 2022 | 909 | $642.5M | Vanguard Short-Term Bond ETFSPLKVanguard Intl Equity Index F | vs. Q4 2021 | SEC |
| Q4 2021 | Feb 1, 2022 | 925 | $670.0M | Vanguard Short-Term Bond ETFVanguard Intl Equity Index FiShares Tr | vs. Q3 2021 | SEC |
| Q3 2021 | Oct 28, 2021 | 946 | $623.6M | Vanguard Intl Equity Index FiShares MSCI USA Momentum Factor ETFSPLK | vs. Q2 2021 | SEC |
| Q2 2021 | Jul 30, 2021 | 946 | $597.0M | iShares MSCI USA Momentum Factor ETFMSFTSPLK | vs. Q1 2021 | SEC |
| Q1 2021 | May 10, 2021 | 791 | $514.5M | Vanguard Intl Equity Index FSPLKiShares MSCI USA Momentum Factor ETF | – | SEC |